DCGI
- India
Prioritize cough syrup testing for exports: DCGI to labs
New Delhi: With India making testing of cough syrups before export mandatory from June 1, the Drugs Controller General of India (DCGI) has asked specified state laboratories to examine such samples from…
- Hyderabad
Hyderabad-based IIL get DCGI nod for Measles-Rubella vaccine
Hyderabad: The vaccine makers based in Hyderabad, Indian Immunologicals Limited (IIL), have received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (TSDCA) for manufacturing its…
- Health
DCGI sends notice to e-pharmacies for selling drugs without license
New Delhi: The Drugs Controller General of India (DCGI) has issued a showcause notice to online pharmacies, seeking an explanation on why action should not be taken against them for selling and…
- Delhi
DGCI approves market authorisation of Serum Institute’s Covovax as booster dose
Delhi: The Drugs Controller General of India (DCGI) has approved the market authorisation of Serum Institute of India’s (SII) COVID-19 vaccine Covovax as a heterologous booster dose. This vaccine can be taken…
- Hyderabad
DCGI approves 14-valent pneumococcal conjugate vaccine
Hyderabad: Biological E. Limited (BE), a Hyderabad-based Pharmaceutical and Vaccine Company Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine, (Investigational Pneumococcal Polysaccharide Conjugate Vaccine PCV14) against S. pneumoniae infection has received…
- India
WHO drew premature link between children’s deaths in Gambia, India-made cough syrups: DCGI
New Delhi: The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country’s pharmaceutical products across…
- India
India’s first intranasal vaccine for COVID-19 gets DCGI approval
New Delhi: India’s first intranasal COVID-19 vaccine by Bharat Biotech on Tuesday got approval from the Drug Controller General of India for the 18+ age group for restricted use in emergency situations.…
- India
DCGI approves indigenous mRNA jab for emergency use for 18 years and above
New Delhi: The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18…
- Hyderabad
Dr Reddy’s gets DCGI nod for single-shot Sputnik Light vaccine
Hyderabad: Dr Reddy’s Laboratories Ltd. on Monday announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situations for…
